TFMFly is a compound related to psychedelic phenethylamines such as 2C-B-FLY and 2C-TFM. It was first reported in 2005 by a team at Purdue University led by David Nichols. It acts as a potent agonist at the 5HT2A serotonin receptor subtype and is a chiral compound with the more active (R) enantiomer having a Ki of 0.12nM at the human 5HT2A receptor.
This page contains content from the copyrighted Wikipedia article "TFMFly"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
